SCHEMBL2484451

SCHEMBL2484451

O=C(Oc1cc(-c2ccccc2)cc(C2CCCC2)c1OC(=O)c1ccccc1)c1ccccc1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KMT2A Q03164 3/20 0.43
ALDH1A1 P00352 2/20 0.43
CYP1A2 P05177 1/20 0.43
CYP2C9 P11712 1/20 0.43
CYP2C19 P33261 1/20 0.43
STAT3 P40763 1/20 0.43
SLC6A9 P48067 1/20 0.41
LHCGR P22888 1/20 0.40
MAPT P10636 2/20 0.40
SMN1; SMN2 Q16637 1/20 0.40
PTGDR2 Q9Y5Y4 2/20 0.39
PTGDR Q13258 1/20 0.39
ESR1 P03372 1/20 0.38
ESR2 Q92731 1/20 0.38
CAMKK1 Q8N5S9 3/20 0.38
CAMKK2 Q96RR4 3/20 0.38
MEN1 O00255 1/20 0.37
LMNA P02545 1/20 0.37
GAA P10253 1/20 0.37
HTT P42858 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2484610 0.99 KMT2A (0.43) KMT2AALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL2484027 0.86 KMT2A (0.44) KMT2AALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL2482272 0.85 KMO (0.46) KMT2AALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL2484042 0.85 KMO (0.46) KMT2AALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL2507641 0.85 KMO (0.46) KMT2AALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL2506366 0.85 PTGDR2 (0.44) KMT2AALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL2506534 0.84 KMT2A (0.43) KMT2AALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL2484864 0.84 PTGDR2 (0.46) KMT2AALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL2510955 0.81 KMT2A (0.41) KMT2AALDH1A1CYP1A2CYP2C9CYP2C19
SCHEMBL2509949 0.81 MAPT (0.46) KMT2AALDH1A1CYP1A2CYP2C9CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8604235-B2 Production of substituted phenylene aromatic diesters and compositions DOW GLOBAL TECHNOLOGIES LLC (US) 2013-12-10 US disclosed
EP-2376423-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS Dow Global Technologies LLC (US) 2011-10-19 EP disclosed
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions W. R. GRACE & CO.-CONN. 2010-08-12 US disclosed
WO-2010078519-A1 PRODUCTION OF SUBSTITUTED PHENYLENE AROMATIC DIESTERS DOW GLOBAL TECHNOLOGIES INC. (US) 2010-07-08 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100204506-A1 Production of Substituted Phenylene Aromatic Diesters and Compositions PAH, DDC, DDT KMT2A 1611/4885ALDH1A1 240/4885CYP1A2 76/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.